Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
4,802 total articles
AMD is trading like a winner of the AI infrastructure era: strong top-line momentum across processors and accelerators, clean balance sheet, and sizable free cash flow, but the stock is richly valued and technically overbought. This trade idea lays out a disciplined long position into earnings with defined risk, a $349 entry, $320 stop and $400 tar…
ServiceNow dropped sharply after guidance and gross-margin noise on 04/23/2026. The market reaction discounted high-quality recurring revenue and $4.58B of free cash flow. With a $94.3B market cap, a PE of 53x, and technicals showing oversold-but-stabilizing action, we view the sell-off as overdone and actionable for a mid-term swing trade to $115 …
Dell is trading near its 52-week high after a sustained run. Behind the move is a structural shift: inference workloads are proliferating outside GPU-dominated training clusters, and that plays to Dell's strengths in CPU-based servers, storage and systems integration. With a sizable server backlog, positive free cash flow, and reasonable valuation …
Palo Alto Networks (PANW) trades richly, but its subscription-driven revenue, $3.57B in free cash flow, rising AI-security momentum and technical strength make a measured long position attractive over the next 180 trading days. This trade plan gives a precise entry at $178.55, a stop at $165.00 and a target of $230.00 with a medium risk posture.
Skilled-labor constraints are pushing companies toward consolidation, strategic partnerships and capital-market solutions. Evercore (EVR) is positioned to monetize that shift via its advisory-first model, strong margins and healthy cash flow. We lay out an actionable long trade with entry, stop and target, plus catalysts and risks.
Oncolytics (ONCY) is trading near $1.05 with a market cap of roughly $115M. Recent regulatory momentum for pelareorep - including Fast Track designation in KRAS-mutant colorectal cancer - and an orderly capital structure set up the company to re-rate if management executes on registrational trials or FDA alignment. This trade idea outlines a long e…
Intuit has been punished on AI angst and sector-wide weakness, but the fundamentals remain intact: $6.9B free cash flow, double-digit ROE, modest leverage and a $109.5B market cap. We upgrade our rating and lay out a clear risk-managed trade with entry at $395.95, stop at $360.00 and a $520.00 target over a 180-trading-day horizon.
Broadcom combines custom AI silicon, entrenched data-center networking franchises, and cash-flow-rich software assets. At today’s levels the stock is richly valued, but momentum, a $29B free cash flow run-rate, and customer traction make a pullback buyable for a 180-trading-day trade targeting further multiple expansion and topping-cycle demand.
Vaalco Energy is showing real operational progress in 2026 — recent Etame development production, the return of the Baobab FPSO, and the sale of non-core Canadian assets have improved cash-flow geometry and refocused the asset-base. At $6.14, shares trade with modest multiples (EV/EBITDA ~4.6) and a supportive quarterly dividend, presenting an acti…
Broadcom's mix of custom AI silicon and infrastructure software positions it to capture outsized data-center spending. The stock is extended but backed by strong cash flow and profitability. This trade idea targets a mid-term rebound while respecting high multiples and near-term technical overbought conditions.
Chewy trades like a recovering growth retailer with defensive demand traits: a $10.8B market cap, a high recurring revenue mix from Autoship, and improving cash flow. At $26.14 the risk/reward favors a long trade targeting $35 over the next 180 trading days, while protecting capital with a $23 stop.
Aurora Cannabis (ACB) trades at a sub-$200M market cap with a P/B near 0.54 and meaningful short interest. Regulatory moves in the U.S., ongoing industry premiumization, and the company’s downsized cost base create an asymmetric risk/reward for a mid-term trade. I outline an entry at $3.385, a stop at $2.90 and a $5.50 target tied to a ~60-65% upsi…
XOP offers a way to buy a diversified, equal-weighted basket of U.S. exploration & production names that have already recovered from 52-week lows but remain below recent highs. With a $3.23B market cap, a 2.07% yield and technicals near neutral, this ETF is a pragmatic swing trade: entry $168.00, stop $160.00, target $190.00 over a mid-term horizon…
Eli Lilly (LLY) has the balance sheet, cash flow, and a leading GLP-1 franchise to recover from recent volatility. The stock is trading off materially from its highs and the technicals are soft, so the trade is a tactical mid-term long: enter at $880.00, stop at $820.00, target $980.00 over ~45 trading days. Keep position size disciplined — this is…
Freeport-McMoRan (FCX) dipped after a Grasberg delay and guidance cut, creating a tactical long opportunity. With market cap around $87.7B, EV/EBITDA near 10.7 and free cash flow of ~$1.12B, the company can ride a copper rebound if supply tightness persists. Trade plan: enter $61.05, target $70.00, stop $57.00 - mid-term (45 trading days) swing.
UnitedHealth (UNH) delivered a convincing Q1, raised full-year guidance and reinstated buybacks, signaling a recovery. Fundamentals have improved - medical cost trends, Optum momentum and $2B in buybacks matter - but technicals are stretched (RSI ~82) and valuation is full. This trade proposes a measured long on a pullback with clear stop and targe…
Medpace remains a high-quality contract research organization with durable free cash flow and elevated margins. Recent weakness has brought the stock down toward technical support and improved entry economics, but multiple securities class actions and book-to-bill questions introduce headline risk. I downgrade my conviction but maintain a Buy trade…
Adobe's shares have been punished on AI worries and technical weakness, but the underlying business still generates healthy margins and free cash flow. With a $25 billion buyback, strong FCF ($10.317B), and valuation metrics that look reasonable (PE ~14.5, EV/EBITDA ~10.1), the stock offers a compelling risk-reward for a long-term trade. This idea …
Information Services Group (III) is trading cheaply relative to its cash generation. A cyclical slowdown has pressured margins and near-term earnings, but ISG's $25m annual free cash flow, modest leverage and a ~4% dividend create a low-risk entry for a long-term trade. Entry $4.05, stop $3.50, target $5.50 over 120 trading days.
Planet Labs is riding favorable sector momentum and meaningful defense wins, but the stock already prices aggressive future growth. We upgrade to a tactical long with a clearly defined entry, stop and target for a long-term (180 trading days) hold — this is a high-risk, high-reward trade that depends on contract execution and sustained margin impro…
Toast just crossed the profitability Rubicon. With $608M in free cash flow, $342M in net income on $6.2B revenue, and an institutional buyer stepping in, the stock offers a favorable asymmetric swing opportunity around $28.35. This trade pairs a clear entry and stop with a realistic upside target backed by improving fundamentals, resilient unit eco…
Alpha Metallurgical (AMR) offers a mid-term buying opportunity. The stock has corrected from its January highs, valuation multiples are reasonable on a P/B basis, and AMR's met coal focus positions it to benefit if import demand from India firm up. The trade is a guarded long with clearly defined entries, stop and target while acknowledging executi…
Wesdome offers exposure to high-grade underground gold production with a compact asset base and clear near-term catalysts (Kiena ramp, drilling results, potential M&A optionality). We set a tactical long trade with a defined entry, stop and target and a long-term horizon to capture operational derisking and re-rating.
Charter (CHTR) plunged into oversold territory after a sharp intra-day move, but the company's cash generation, low earnings multiple and clear operational catalysts make a controlled long the highest-probability trade. Entry at $184.94, stop at $174.00, target $258.11 — mid-term setup with room to extend on confirming data.
CAE is trading like it will re-accelerate into 2027, but legacy Defense contract issues, a lowered EPS growth target and stretched valuation argue otherwise. This note lays out a short trade: entry $25.25, stop $28.50, target $20.00, horizon 180 trading days. Catalyst calendar and risk checklist included.
